GlassScriptPhysician profile
Michael L Paik
NPI 1437247327
$6,516.58
in general payments reported to CMS, 2019-2025
44 companies · $1,553 in 2025
The $1,553 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $936 · 2020: $132 · 2021: $815 · 2022: $1,246 · 2023: $959 · 2024: $876 · 2025: $1,553.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,388.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,388.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Urogen Pharma, INC. | $669.06 | 2021-2025 | Jelmyto |
| Teleflex LLC | $655.03 | 2022-2025 | Urolift, Barrigel |
| Astellas Pharma US INC | $611.53 | 2019-2025 | Xtandi, Myrbetriq |
| Pfizer INC. | $528.74 | 2019-2025 | |
| Janssen Biotech, INC. | $482.12 | 2019-2025 | Erleada |
| Sumitomo Pharma America, INC. | $290.99 | 2023-2025 | Gemtesa, Orgovyx |
| Dendreon Pharmaceuticals LLC | $290.60 | 2019-2025 | Provenge |
| Bayer Healthcare Pharmaceuticals INC. | $231.43 | 2019-2025 | |
| Boston Scientific Corporation | $207.07 | 2019-2023 | Rezum Generator |
| Merck Sharp & Dohme LLC | $176.47 | 2021-2024 | Keytruda, Lynparza |
| Laborie Medical Technologies Corp. | $160.33 | 2023-2025 | Optilume Bph Drug Coated Balloon Catheter |
| Medtronic, INC. | $149.86 | 2022 | |
| 180 Medical, INC. | $146.54 | 2022-2024 | Gentlecath, Gentlecath Glide |
| Convatec INC. | $137.88 | 2021-2024 | |
| Myovant Sciences INC. | $130.38 | 2022 |
Show all 44 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Antares Pharma, INC. | $126.06 | 2022-2025 | Xyosted |
| Ferring Pharmaceuticals INC. | $120.59 | 2019 | |
| Tolmar, INC. | $118.07 | 2025 | Eligard, Jatenzo |
| Travere Therapeutics, INC. | $109.16 | 2019-2020 | |
| Coloplast Corp | $107.68 | 2019-2023 | Speedicath |
| Endo Pharmaceuticals INC. | $102.81 | 2019-2023 | Xiaflex, Aveed |
| Rochester Medical Corporation | $97.80 | 2021-2022 | |
| Abbvie INC. | $96.33 | 2019-2024 | |
| Genzyme Corporation | $73.17 | 2021-2022 | |
| Tolmar Pharmaceuticals, INC. | $66.42 | 2021 | |
| Novartis Pharmaceuticals Corporation | $65.36 | 2025 | |
| Procept Biorobotics Corporation | $65.06 | 2025 | |
| Urovant Sciences INC | $64.01 | 2022 | |
| Mission Pharmacal Company | $57.08 | 2019-2023 | Uribel |
| Becton, Dickinson and Company | $46.45 | 2023 | Bard Urinary Drainage Bag |
| Axonics, INC. | $42.86 | 2022 | |
| Endo USA, INC. | $37.53 | 2024-2025 | Xiaflex |
| Allergan, INC. | $31.88 | 2019 | |
| Blue Earth Diagnostics | $31.79 | 2019-2021 | |
| Amgen INC. | $25.21 | 2020 | |
| Immunitybio, INC. | $24.03 | 2024 | |
| Abbott Laboratories | $23.39 | 2022 | |
| Olympus America INC. | $21.29 | 2019 | |
| Foundation Medicine, INC. | $20.42 | 2021 | |
| C. R. Bard, INC. & Subsidiaries | $19.02 | 2025 | Bard Urinary Drainage Bag |
| Hollister Incorporated | $16.12 | 2023 | Vapro Pocket, Vapro |
| Davol INC. | $13.38 | 2023 | Arista Ah Flexitip |
| Myriad Genetic Laboratories, INC. | $13.21 | 2022 | |
| Zyla Life Sciences, INC. | $12.37 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Paik listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.